By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Startup molecular diagnostics firm Sequenta today announced the close of a Series B financing round that raised $13 million, which it will use toward developing a technology that the San Francisco-based firm said could enable new models for treating diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.